The global healthcare industry experienced a 37% decline in the number of artificial intelligence-related patent applications in Q3 2022 compared with the previous quarter. The total number of artificial intelligence-related grants rose by 2% in Q3 2022, according to GlobalData’s whitepaper on Artificial Intelligence in Healthcare – Patenting Activity in Q3 2022.

Notably, the number of artificial intelligence-related patent applications in the healthcare industry was 1,314 in Q3 2022, versus 2,072 in the prior quarter.

The top five companies accounted for 9% of patenting activity

Analysis of patenting activity by companies shows that Koninklijke Philips filed the most artificial intelligence patents within the healthcare industry in Q3 2022. The company filed 32 artificial intelligence-related patents in the quarter, compared with 39 in the previous quarter. It was followed by Medtronic with 24 artificial intelligence patent filings, Ping An Insurance (Group)of China Ltd (22 filings), and Siemens (21 filings) in Q3 2022.

Patenting activity was driven by the US with a 35% share of total patent filings

The largest share of artificial intelligence related patent filings in the healthcare industry in Q3 2022 was in the US with 35%, followed by China (19%) and South Korea (13%). The share represented by the US was 4% higher than the 31% share it accounted for in Q2 2022.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.